Skip to main content

Table 1 The HBV-related cohorts in CCI-HBV areas

From: Establishment and development of national community-based collaborative innovation demonstration areas to achieve the control target of hepatitis B in China

CCI area of diseases Group Cohort Target capacity by 2020 Present capacity (2015)
HBV Uninfected HBV new infection rates in the general population cohort > 1,000,000 1,360,000
Adult HBV vaccination intervention cohort > 500,000 639,799
Infected HBV carrier cohort > 50,000 70,890
Chronic HBV antiviral treatment cohort > 30,000 34,083
Hepatic cirrhosis antiviral treatment cohort > 2000 2257